Product image (placeholder)

VIDIA

MONO-VIDITEST anti-Borrelia recombinant IgM

REF KZ-301-12 · Mono-cassette · 12 tests · IgM antibodies

CE IVDCE IVDDFor in vitro diagnostic use only

Popis

MONO-VIDITEST anti-Borrelia recombinant IgM - Cassette mono-test intended for semiquantitative and quantitative determination of IgM antibodies against pathogenic Borrelia strains (B. afzelii, B. garinii, B. burgdorferi s.s. and B. spielmanii) in human serum, plasma, cerebrospinal fluid and synovial fluid, and for estimation of intrathecal antibody production. The test is used in the diagnosis of early stages of Lyme borreliosis, including erythema migrans, lymphocytoma and early neuroborreliosis. IgM antibodies are detectable approximately 3 weeks after infection, peak around week 6, and then decrease as IgG antibodies develop. The Antibody Index (AI) can be determined for CSF. The kit is intended for professional use.

Parametry soupravy

REF
KZ-301-12
Pathogen
Borrelia
Detected marker
IgM antibodies
Method
MONO
Format
Mono-cassette
Number of tests
12 tests
Sample type
Serum / Plasma / Cerebrospinal fluid (CSF) / Synovial fluid
Evaluation
Qualitative, Semiquantitative, Quantitative
Testing option
Intrathecal synthesis
Incubation
30 min (37°) / 30 min (37°) / 15 min (RT)
Product line
MONO-VIDITEST

Obsah soupravy

  • MONO-VIDITEST cassettes with RF sorbent
  • STOP solution
  • Instructions for use
  • Quality control certificate